Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-21-060910

Chief Financial Officer sold 7,229 shares at an average $55.44 ($400,793)

  • Chief Financial Officer acquired 7,229 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GARCIA PETER S · Chief Financial Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-18 Exercise or conversion : show line 1 in the form +7,229 $4.08 $29,494 16,560 D
2021-10-18 Sale : show line 2 in the form −2,851 $54.33 $154,884 13,709 D
2021-10-18 Sale : show line 3 in the form −1,903 $55.15 $104,958 11,806 D
2021-10-18 Sale : show line 4 in the form −1,437 $56.09 $80,603 10,369 D
2021-10-18 Sale : show line 5 in the form −411 $57.54 $23,648 9,958 D
2021-10-18 Sale : show line 6 in the form −438 $58.30 $25,537 9,520 D
2021-10-18 Sale : show line 7 in the form −189 $59.06 $11,163 9,331 D
Open-market sales · 7,229 sh · avg $55.44 · $400,793

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-10-18 Exercise or conversion : show line 8 in the form Employee Stock Option (right to buy) −7,229 60,468 D
Loading xslF345X03/doc4.xml…